We are continuing to carry out important secondary data analysis of the stored data and biosamples collected from the SCOPE cohort, for example data from the SCOPE cohort is currently being used in the IDEA project.
A summary of the outputs from SCOPE data from June 2021-June 2022 is outlined below:
1: Maher GM, Khashan AS, O’Byrne L, Flanagan S, Mortimer RM, Kiely M, O’B Hourihane J, Kenny LC, Murray D, McCarthy FP. Periconceptual and prenatal alcohol consumption and neurodevelopment at age two and five years. Eur J Obstet Gynecol Reprod Biol. 2022 Jul;274:197-203. doi: 10.1016/j.ejogrb.2022.05.034. Epub 2022 May 31. PMID: 35667175.
2: Carter M, Casey S, O’Keeffe GW, Gibson L, Murray DM. Mid-gestation cytokine profiles in mothers of children affected by autism spectrum disorder: a case-control study. Sci Rep. 2021 Nov 16;11(1):22315.
3: Casey S, Carter M, Looney AM, Livingstone V, Moloney G, O’Keeffe GW, Taylor RS, Kenny LC, McCarthy FP, McCowan LME, Thompson JMD, Murray DM; SCOPE Consortium. Maternal Mid-Gestation Cytokine Dysregulation in Mothers of Children with Autism Spectrum Disorder. J Autism Dev Disord. 2021 Sep 9.
4: Morillon AC, Leite DFB, Yakkundi S, Gethings LA, Thomas G, Baker PN, Kenny LC, English JA, McCarthy FP. Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort. Metabolomics. 2021 Jan 5;17(1):5. doi: 10.1007/s11306-020-01740-9. PMID: 33398476; PMCID: PMC7782411.
Should you wish to obtain more information regarding the continued storage of your samples and data please contact: Dr Fergus McCarthy email@example.com